Welcome to the InFLAMES Research Flagship’s Corporate Corner titled Novel Technologies to Improve Human Health on Thursday May 11th, 2023 at 11:45–16:00. The event will be held in Cave Theatre, Visitor and Innovation Centre Joki, Lemminkäisenkatu 12b, Turku. The event starts with lunch at 11:45 and you are welcome to the networking event at Sokos Hotel Kupittaa after the official programme from 16:00.

In recent years, various novel technologies have shown their potential as powerful tools in the quest to improve human health. These technologies have the ability to revolutionise the way we diagnose, treat, and prevent diseases, allowing us to unlock new insights into the complexities of the human body and develop more effective therapies for a wide range of illnesses. As such, the exploration and development of these novel technologies remain at the forefront of efforts to advance human health and well-being. The InFLAMES Corporate Corner delves into this subject and presents different solutions from our speakers in this area. We have a great list of speakers from InFLAMES, Brinter, Finnadvance, Finnish Red Cross Blood Service, Gilead, ImaginAb, and Olink.

All interested parties are welcome. SING UP HERE! (closes on May 3)

Host of the event is Academy Research Fellow Maija Hollmén, MediCity Research Laboratory, University of Turku, Finland

Programme

11:45-12:15          Lunch (can be enjoyed during presentations)

12:15-13:40 

Opening words, Maija Hollmén

Biological image analysis in the deep learning era
Associate Professor Guillaume Jacquemet, Faculty of Science and Engineering, Åbo Akademi University

Organ-on-chip technology to study immune cells migration and therapy delivery
Chief Scientific Officer Sebastien Mosser, AKITA, by Finnadvance

The Broad possibilities of stem cell research and reprogramming technology for human health
Adjunct Professor in Stem Cell Science Elisa Närvä, Institute of Biomedicine, Pluripotency & Cancer Laboratory, University of Turku

Multimaterial 3D bioprinting with Brinter
Chief Scientific Officer Antti Arjonen, Brinter

Precision proteomics broadens MultiOmics repertoire and enables biomarker discovery
Scientific Director-MultiOmics Sarantis Chlamydas & Business Development Specialist, Camille Ridde,  Olink Proteomics

13:40-14:15          Break (coffee/tea and dessert)

14:15-16:00

Blood cell derived extracellular vesicles – Future therapy?
R&D Manager Saara Laitinen, Finnish Red Cross Blood Service

Anti-viral treatment in glioblastoma patients; a new therapy option?
Professor Cecilia Söderberg-Naucler, Institute of Biomedicine, University of Turku

Gilead/Kite – Innovative cancer treatments
Senior Medical Managers Tuuli Ranki and Joni Alvesalo, Gilead

CD8 ImmunoPET: Imaging the immune system with 89Zr-Crefmirlimab Berdoxam
VP Business Strategy Gareth Smith, ImaginAb

The basics of starting a limited liability company
Legal Counsel Perttu Tuuppa, University of Turku

InFLAMES Idea Competition – Award Ceremony
Head of Business Development Anne Marjamäki, Innovation Services, University of Turku and Professor of Practice Timo Veromaa, University of Turku

InFLAMES Corporate Corner Competition
Organised by Maija Hollmen, InFLAMES Project Manager Kaisa Hakkila and InFLAMES Research Coordinator Sampo Koivunen

16:00 – 19:00
Networking at Sokos Hotel Kupittaa over drinks and snacks
(The official networking event ends at 19:00. However, attendees are welcome to stay longer after the scheduled end time and continue discussion.)

Companies on stage are:

The event is part of the 80th Anniversary of the Faculty of Medicine. The main sponsor of the 80th Anniversary is Planmeca Group.